Mediator-directed therapy in pancreatitis and trauma

Sepsis

Volumn 3, Issue 1, 1999, Pages 57-64

  Nathens, Avery B ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Adhesion molecules; IL 10; IL 1Ra; Neutrophil; Pancreatitis; Platelet activating factor; TNF ; Trauma

Indexed keywords

CD18 ANTIBODY; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; L SELECTIN ANTIBODY; LEXIPAFANT; PADGEM PROTEIN ANTIBODY; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; TUMOR NECROSIS FACTOR ANTIBODY; UNCLASSIFIED DRUG;

ACUTE RESPIRATORY TRACT DISEASE; CONFERENCE PAPER; CYTOKINE PRODUCTION; DRUG MECHANISM; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; PANCREAS INJURY; PANCREATITIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 0032826351     PISSN: 13850229     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009826709338     Document Type: Conference Paper

References (65)

1. Bradley EL. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch Surg 1993;128:586-590.
2. Yates DW. ABC of major trauma. Scoring systems for trauma. Br Med J 1990;10:1090-1094.
3. Paran H, Neufeld D, Mayo A, Schwartz I, Singer P, Kaplan O, et al. Preliminary report of a prospective randomized study of octreotide in the treatment of severe acute pancreatitis. J Am Coll Surg 1995;181:121-124.
4. Pink GW, Norman JG. Specific changes in the pancreatic expression of the interleukin 1 family of genes during experimental acute pancreatitis. Cytokine 1997;9:1023-1027.
5. Norman J. The role of cytokines in the pathogenesis of acute pancreatitis. Am J Surg 1998;175:76-83.
6. Norman J, Franz M, Riker A, et al. Rapid elevation of proinflammatory cytokines during acute pancreatitis and their origination within the pancreas. Surg Forum 1994; 148-160.
7. Zhou W, Levine BA, Olson MS. Lipid mediator production in acute and chronic pancreatitis in the rat. J Surg Res 1994; 56:37-44.
8. Konturek SJ, Dembinski A, Konturek PJ, Warzecha Z, Jaworek J, Gustaw P, Tomaszewska R, Stachura J. Role of platelet activating factor in pathogenesis of acute pancreatitis in rats. Gut 1992;33:1268-1274.
9. Van-Laethem JL, Eskinazi RX, Rickaert P, Robberecht P, Deviere J. Multisystemic production of IL-10 limits the severity of acute pancreatitis in mice. Gut 1998;43:408-413.
10. Gloor B, Todd KE, Lane JS, Rigberg DA, Reber HA. Mechanism of increased lung injury after acute pancreatitis in IL-10 knockout mice. J Surg Res 1998;80:110-114.
11. Denham W, Yang J, Norman J. Evidence for an unknown component of pancreatic ascites that induces adult respiratory distress syndrome through an interleukin-1 and tumor necrosis factor-dependent mechanism. Surgery 1997;122: 295-301.
12. Norman JG, Fink GW, Denham W, Yang J, Carter G, Sexton C, Falkner J, Gower WR, Franz MG. Tissue-specific cytokine production during experimental acute pancreatitis. A probable mechanism for distant organ dysfunction. Dig Dis Sci 1997;42:1783-1788.
13. Oezcueruemez-Porsch M, Kunz D, Hardt PD, Fadgyas T, Kress O, Schulz HU, et al. Diagnostic relevance of interleukin pattern, acute phase proteins, and procalcitonin in early phase of post-ERCP pancreatitis. Dig Dis Sci 1998;43: 1763-1769.
14. Exley AR, Leese T, Holliday MP, Swann RA, Cohen J. Endotoxemia and serum TNF as prognostic markers in severe acute pancreatitis. Gut 1992;33:1126-1128.
15. De Beaux AC, Goldie AS, Ross JA, Carter DC, Fearon KCH. Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis. Br J Surg 1996;83:349-353.
16. Grewal HP, Kotb M, El Din AM, Ohman M, Salem A, Gaber L, Gaber AO. Induction of tumor necrosis factor in severe acute pancreatitis and its subsequent reduction after hepatic passage. Surgery 1994;115:213-221.
17. Montravers P, Chollet-Martin S, Marmuse JP, Gougerot-Pocidalo MA, Desmonts JM. Lymphatic release of cytokines during acute lung injury complicating severe pancreatitis. Am J Respir Crit Care Med 1995;152:1527-1533.
18. Heresbach D, Letourneur JP, Bahon I, Pagenault M, Guillou Y-M, Dyard P, Fauchet R, Malledant Y, Bretagne J-F, Gosselin M. Value of early blood TH-1 cytokine determination in predicting severity of acute pancreatitis. Scand J Gastroeterol 1998;33:554-560.
19. Pezzilli R, Billi P, Miniero R, Barakat B. Serum IL-10 in human acute pancreatitis. Dig Dis Sci 1997;42:1469-1472.
20. Hughes CB, Gaber LW, El-Din ABM, Grewal HP, Kotb M, Mann L, Gaber AO. Inhibition of TNF improves survival in an experimental model of acute pancreatitis. Am Surg 1996;62:8-13.
21. Norman JG, Fink GW, Messina J, Carter G, Franz MG. Timing of tumor necrosis factor antagonism is critical in determining outcome in murine lethal pancreatitis. Surgery 1996;120:515-521.
22. Norman JG, Franz MG, Fink GS, Messina J, Fabri PJ, Gower WR, Carey LC. Decreased mortality of severe acute pancreatitis after proximal cytokine blockade. Ann Surg 1995;221:625-634.
23. Norman J, Yang J, Fink G, Carter G, Ku G, Denham W, Livingston D. Severity and mortality of experimental pancreatitis are dependent on IL-1 converting enzye (ICE). J Interferon Cytokine Res 1997;17:113-118.
24. Fisher CJ, Dhainaut J-FA, Opal SM, Pribble JP, Balk RA, Slotman GJ, Iberti TJ, Rackow EC, Shapiro MJ, Greenman RL, Reines HD, Shelly MP, Thompson BW, LaBrecque JF, Catalano MA, Knaus WA, Sadoff JC. Recombinant human interleukin-1 receptor antagonist in the treatment of patients with sepsis syndrome: Results from a randomized, double-blind, placebo controlled trial. JAMA 1995;271: 1836-1843.
25. Kusske AM, Bangione AJ, Ashley SW, McFadder DWX, Reber HA. IL-10 prevents death in lethal necrotizing pancreatitis. Surgery 1996;120:284-289.
26. Osman MO, Jocobsen NO, Kristensen JU, Deleuran B, Gesser B, Larsen CG, Jensen SL. IT-9302, a synthetic IL-10 agonist, diminishes acute lung injury in rabbits with acute necrotizing pancreatitis. Surgery 1998;124:584-592.
27. Formela LJ, Wood LM, Whittaker M, Kingsnorth AN. Amelioration of experimental acute pancreatitis with a potent platelet-activating factor antagonist. Br J Surg 1994; 81:1783-1785.
28. Galloway SW, Kingsnorth AN. Lung injury in the microembolic model of acute pancreatitis and amelioration by lexipafant, a platelet-activating factor antagonist. Pancreas 1996;13:140-146.
29. Rivera JA, Werner J, Warshaw AL, Lewandrowski KB, Rattner DW, Fernandez-del Castillo C. Lexipafant fails to improve survival in severe necrotizing pancreatitis in rats. Int J Pancr 1998;23:101-106.
30. McKay CJ, Curran F, Sharples C, Baxter JN, Imrie CW. Prospective placebo-controlled randomized trial of lexipafant in predicted severe acute pancreatitis. Br J Surg 1997;84:1239-1243.
31. Kingsnorth AN, Galloway SW, Formela LJ. Randomized double blind phase II trial of lexipafant, a PAF antagonist, in human acute pancreatitis. Br J Surg 1995;82:1414-1420.
32. Heckbert SR, Vedder NB, Hoffman W, Winn RK, Hudson LD, Jurkovich GJ, Copass MK, Harlan JM, Rice CL, Maier RV. Outcome after hemorrhagic shock in trauma patients. J Trauma 1998;45:545-549.
33. Roumen RMH, Redl H, Schlag G, et al. Inflammatory mediators in relation to the development of multiple organ failure in patients after severe blunt trauma. Crit Care Med 1995;23:474-480.
34. Barroso-Aranda J, Chavez-Chavez RH, Schmid-Schonbein GW. Spontaneous neutrophil activation and the outcome of hemorrhagic shock in rabbits. Circ Shock 1992;36:185-190.
35. Barroso-Aranda J, Schmid-Schonbein GW. Transformation of neutrophils as indicator of irreversibility in hemorrhagic shock. Am J Physiol 1989;257:H846-H852.
36. Lindsay TP, Memari N, Ghanekar A, Walkper P, Romaschin A. Rupture of an abdominal aortic aneurysm causes priming of phagocytic oxidative burst. J Vasc Surg 1997;25: 599-610.
37. Nuytinck HKS, Offermans X, Kubat K, Goris JA. Whole-body inflammation in trauma patients. Arch Surg 1988;123: 1519-1524.
38. Smith SM, Holm MA, Perry MB, Grisham MB, Arfors KE, Granger DN. Role of neutrophils in hemorrhagic shock-induced gastric mucosal injury in the rat. Gastroenterology 1987;93:466-471.
39. Kapoor R, Prasad K. Role of polymorphonuclear leukocytes in cardiovascular depression and cellular injury in hemorrhagic shock and reinfusion. Free Radic Biol Med 1996; 21:609-618.
40. Patel KD, Zimmerman GA, Prescott SM, McEver RP, McIntyre TM. Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils. J Cell Biol 1991; 112:749-759.
41. DeForge LE, Preston AM, Takeuchi E, Kenney J, Boxer LA, Remick DG. Regulation of IL-8 gene expression by oxidant stress. J Biol Chem 1993;268:25568-25576.
42. Mendez C, Garcia I, Maier RV. Oxidants augment endotoxin-induced activation of alveolar macrophages. Shock 1996;6: 157.
43. Kawai M, Nishikomori R, Jung E-Y, Tai G, Yamanaka C, Mayumi M, Heike T. Pyrrolidine dithiocarbamate inhibits intercellular adhesion molecule-1 biosynthesis induced by cytokines in human fibroblasts. J Immunol 1995;154: 2333-2341.
44. Fialkow L, Chan CK, Rotin D, Grinstein S, Downey GP. Activation of the mitogen-activated protein kinase signaling pathway in neutrophils: Role of oxidants. J Biol Chem 1994;269:31234-31242.
45. Vedder NB, Winn RK, Rice CL, Chi EY, Arfors KE, Harlan JM. A monoclonal antibody to the adherence promoting leucocyte glycoprotein, CD18, reduces organ injury and improves survival from hemorrhagic shock and resuscitation in rabbits. J Clin Invest 1988;81:939-944.
46. Vedder NB, Fouty BW, Winn RK, Harlan JM. Role of neutrophils in generalized reperfusion injury associated with resuscitation from shock. Surgery 1989;106:509-516.
47. Ramamoorthy C, Sharar SR, Harlan JM, Tedder TF, Winn RK. Blocking L-selectin function attenuates reperfusion injury following hemorrhagic shock in rabbits. Am J Physiol 1996;271:H1871-H1877.
48. Winn RK, Paulson JC, Harlan JM. A monoclonal antibody to P-selectin ameliorates injury associated with hemorrhagic shock in rabbits. Am J Physiol 1994;267:H2391-H2397.
49. Rivera-Chavez P, Toledo-Pereyra LH, Nora DT, Bachulis B, Ilgenfritz F, Dean RE. P-selectin blockade is beneficial after uncontrolled hemorrhagic shock. J Trauma 1998;45:440-445.
50. Rizoli SB, Kapus A, Fan J, Li YH, Marshall JC, Rotstein OD. Immunomodulatory effects of hypertonic resuscitation on the development of lung inflammation following hemorrhagic shock. J Immunol 1998;161:6288-6296.
51. Vassar MJ, Fischer RP, O'Brien PE, Bachulis BL, Chambers JA, Hoyt DB, et al. A multicenter trial for resuscitation of injured patients with 7.5% sodium chloride: The effect of added dextran 70. Arch Surg 1993;128:1003-1013.
52. Deitch EA, Xu D, Franko L, Ayala A, Chaudry IH. Evidence favoring the role of the gut as a cytokine-generating organ in rats subjected to hemorrhagic shock. Shock 1994;1:141-146.
53. Tamion F, Richard V, Lyoumi S, Daveau M, Bonmarchand G, Leroy J, Thuillez C, Lebreton J-P. Gut ischemia and mesenteric synthesis of inflammatory cytokines after hemorrhagic or endotoxic shock. Am J Physiol 1997;273:G314-G321.
54. Foex BA, Quinn JV, Little RA, Shelly MP, Slotman GJ. Differences in eicosanoid and cytokine production between injury/hemorrhage and bacteremic shock in the pig. Shock 1997;8:276-283.
55. Stylianos S, Wakabayashi G, Gelfand JA, Harris BH. Experimental hemorrhage and blunt trauma do not increase circulating TNF J Trauma 1991;31:1063-1067.
56. Martin C, Boisson C, Haccoun M, Thomachot L, Mege J-L. Patterns of cytokine evolution (TNF, IL-6) after septic shock, hemorrhagic shock, and severe trauma. Crit Care Med 1997;25:1813-1819.
57. Rabinovici R, John R, Esser KM, Vernick J, Feuerstein G. Serum TNF profile in trauma patients. J Trauma 1993;35: 698-702.
58. Tan LR, Waxman K, Scannell G, Ioli G, Granger GA. Trauma causes early release of soluble receptors for TNF. J Trauma 1993;34:634-638.
59. Seekamp A, Jochum M, Ziegler M, van Griensven M, Martin M, Regel G. Cytokines and adhesion molecules in elective and accidental trauma-related ischemia/reperfusion. J Trauma 1998;44:874-882.
60. Marzi I, Bauer M, Secchi A, Bahrami S, Redl H, Schlag G. Effect of anti-TNF on leukocyte adhesion in the liver after hemorrhagic shock: an intravital microscopic study in the rat. Shock 1995;3:27-33.
61. Bahrrami S, Yao Y, Leichtfried G, Redl H, Marzi I, Schlag G. Significance of TNF in hemorrhage-related hemodynamic alterations, organ injury, and mortality in rats. Am J Physiol 1997;41:H2219-H2226.
62. Pellicane JV, DeMaria EJ, Abd-Elfattah A, Reines HD, Vannice JL, Carson KW. IL-1Ra improves survival and preserves organ adenosine-5′ triphosphate after hemorrhagic shock. Surgery 1993;114:278-284.
63. Bauer C, Marzi I, Bauer M, Fellger H, Larsen R. IL-1Ra attenuates leukocyte-endothelial interactions in the liver after hemorrhagic shock in the rat. Crit Care Med 1995;23: 1099-1105.
64. Mileski WJ, Winn RK, Vedder NB, Pohlman TH, Harlan JM, Rice CL. Inhibition of CD18-dependent neutrophil adherence reduces organ injury after hemorrhagic shock in primates. Surgery 1990;108:206-212.
65. Zingarelli B, Squadrito P, Altavilla D, Calapai G, Di Rosa M, Caputi AP. Role of TNF in acute hypovolemic hemorrhagic shock in rats. Am. J. Physiol. 1994;35:H1512-H1515.